Showing 1 - 9 results of 9 for search 'Ankit K. Desai', query time: 0.03s Refine Results
  1. 1
    Characterization of immune response in Cross-Reactive Immunological Material (CRIM)-positive infantile Pompe disease patients treated with enzyme replacement therapy

    Characterization of immune response in Cross-Reactive Immunological Material (CRIM)-positive infantile Pompe disease patients treated with enzyme replacement therapy by Ankit K. Desai, Zoheb B. Kazi, Deeksha S. Bali, Priya S. Kishnani

    Published 2019-09-01
    Get full text
    Article
  2. 2
    A favorable outcome in an infantile-onset Pompe patient with cross reactive immunological material (CRIM) negative disease with high dose enzyme replacement therapy and adjusted immunomodulation

    A favorable outcome in an infantile-onset Pompe patient with cross reactive immunological material (CRIM) negative disease with high dose enzyme replacement therapy and adjusted im... by Shiri Curelaru, Ankit K. Desai, Daniel Fink, Yoav Zehavi, Priya S. Kishnani, Ronen Spiegel

    Published 2022-09-01
    Get full text
    Article
  3. 3
    Benefits of Prophylactic Short-Course Immune Tolerance Induction in Patients With Infantile Pompe Disease: Demonstration of Long-Term Safety and Efficacy in an Expanded Cohort

    Benefits of Prophylactic Short-Course Immune Tolerance Induction in Patients With Infantile Pompe Disease: Demonstration of Long-Term Safety and Efficacy in an Expanded Cohort by Ankit K. Desai, Carolyn H. Baloh, John W. Sleasman, Amy S. Rosenberg, Priya S. Kishnani

    Published 2020-08-01
    Get full text
    Article
  4. 4
    Development of high sustained anti-drug antibody titers and corresponding clinical decline in a late-onset Pompe disease patient after 11+ years on enzyme replacement therapy

    Development of high sustained anti-drug antibody titers and corresponding clinical decline in a late-onset Pompe disease patient after 11+ years on enzyme replacement therapy by Katherine H. Kim, Ankit K. Desai, Erika R. Vucko, Tracy Boggs, Priya S. Kishnani, Barbara K. Burton

    Published 2023-09-01
    Get full text
    Article
  5. 5
    A Race Against Time—Changing the Natural History of CRIM Negative Infantile Pompe Disease

    A Race Against Time—Changing the Natural History of CRIM Negative Infantile Pompe Disease by Punita Gupta, Brian J. Shayota, Ankit K. Desai, Fuad Kiblawi, Dorothy Myridakis, John Messina, Peter Tah, Lorien Tambini-King, Priya S. Kishnani

    Published 2020-09-01
    Get full text
    Article
  6. 6
    Immunophenotype associated with high sustained antibody titers against enzyme replacement therapy in infantile-onset Pompe disease

    Immunophenotype associated with high sustained antibody titers against enzyme replacement therapy in infantile-onset Pompe disease by Ankit K. Desai, P. Brian Smith, P. Brian Smith, John S. Yi, Amy S. Rosenberg, Trevor D. Burt, Trevor D. Burt, Priya S. Kishnani

    Published 2024-01-01
    Get full text
    Article
  7. 7
    An updated management approach of Pompe disease patients with high-sustained anti-rhGAA IgG antibody titers: experience with bortezomib-based immunomodulation

    An updated management approach of Pompe disease patients with high-sustained anti-rhGAA IgG antibody titers: experience with bortezomib-based immunomodulation by Ankit K. Desai, Garima Shrivastava, Christina L. Grant, Raymond Y. Wang, Raymond Y. Wang, Trevor D. Burt, Trevor D. Burt, Priya S. Kishnani

    Published 2024-03-01
    Get full text
    Article
  8. 8
    Immune Tolerance-Adjusted Personalized Immunogenicity Prediction for Pompe Disease

    Immune Tolerance-Adjusted Personalized Immunogenicity Prediction for Pompe Disease by Anne S. De Groot, Anne S. De Groot, Ankit K. Desai, Sandra Lelias, S. M. Shahjahan Miah, Frances E. Terry, Sundos Khan, Cindy Li, John S. Yi, Matt Ardito, William D. Martin, Priya S. Kishnani

    Published 2021-06-01
    Get full text
    Article
  9. 9
    Optimizing treatment outcomes: immune tolerance induction in Pompe disease patients undergoing enzyme replacement therapy

    Optimizing treatment outcomes: immune tolerance induction in Pompe disease patients undergoing enzyme replacement therapy by Hui-An Chen, Hui-An Chen, Hui-An Chen, Rai-Hseng Hsu, Rai-Hseng Hsu, Rai-Hseng Hsu, Ching-Ya Fang, Ankit K. Desai, Ni-Chung Lee, Ni-Chung Lee, Ni-Chung Lee, Wuh-Liang Hwu, Wuh-Liang Hwu, Wuh-Liang Hwu, Fuu-Jen Tsai, Priya S. Kishnani, Yin-Hsiu Chien, Yin-Hsiu Chien, Yin-Hsiu Chien

    Published 2024-04-01
    Get full text
    Article

Search Tools: